by Raynovich Rod | Aug 12, 2019 | Biopharmaceuticals, Clinical Diagnostics and Tools, Macro
Update-3…8/16 Big reversal day…summary this weekend with XBI up 2.65% at $82.46 just above support. Update-2… 8/14 Nowhere to hide from Global economic fears-welcome to whipsaw trading. Technicals matter not tweets. Market averages down about 3%...
by Raynovich Rod | Jun 30, 2019 | Biopharmaceuticals
Update-1 A bit of a sell-off in gene therapy but MGTX at new highs at $29.44. Profit taking on Sarepta down 3.84% to $150.59. Roche (RHHBY) and Merck (MRK) near new highs. Mid-caps mixed but Novacure (NVCR) rally 3.27% toward new highs. One of our top picks Amarin...
by Raynovich Rod | Jun 24, 2019 | Biopharmaceuticals, Macro
Update-2… 6/27 2p EDT…Good day for gene therapy stocks My longs CRSP and MGTX are up. Looking better all across the screen in biopharma. Added to ABBV and XNCR yesterday. XBI up but still under $86. Update-1… Another Big Deal in Biotech in a weak...
by Raynovich Rod | Jun 10, 2019 | Biopharmaceuticals, Macro
Update-3 6/17 11:30 a EDT Pfizer (PFE) $11B Buyout of Array Pharmaceuticals (ARRY) Sparks Rally in biotech. As usual M&A brings buyers into biotech. ARRY up 56% on Pfizer $11B buyout. XBI up 3.68% to $84.46. Green screen in mid-caps, gene therapy. ==========...
by Raynovich Rod | May 21, 2019 | Biopharmaceuticals, Macro
Update-2…3:15p EDT…. Mixed day-new post after close, XBI down 0.64%, IBB down 0.94%,, Dow sell-off down 0.43%. ====== Update-1 5/22… Not much follow-through from yesterday but trade-able.A horrible news week with politics, tariffs, chips and China...
by Raynovich Rod | May 12, 2019 | Biopharmaceuticals
Update-3 12:30 P EDT ASCO Rally seems too be kicking in.Green Screen! Update-2 5/15 10;45a EDT Gene therapy and mid-cap biopharma getting traction this am.XBI up 0.7% to $82.44. Update-1 5/14 3:30P EDT,Mid and small cap biotechs rally with NASDAQ, XBI up over 2%. Per...
by Raynovich Rod | Apr 7, 2019 | Biopharmaceuticals
4/11 ALERT: Need to check out reasons for biotech sell-off; could be proposed drug pricing bills and “affordability board.” See STAT News . See 4/11 chart below for XBI. Choppy pattern returns at resistance with no breakthrough highs. Biopharma stocks...
by Raynovich Rod | Mar 22, 2019 | Biopharmaceuticals
Update -2 March 24…Concerns about global growth, an inverted TSY yield curve and the German 10 year bond yield dropping below 10% triggered a major sell-off on Friday.The Russell 2000 dropped 3.62%. and the XBI dropped 4.62%. For the week ending 3/22: the XBI...
by Raynovich Rod | Mar 17, 2019 | Biopharmaceuticals
ALERT 3/21/19…BIOGEN (BIIB) down 28% to $233 after dropping Alzheimer’s Disease late stage trial; another failed clinical stage drug in AD. (more later). IBB down 2.5%. ====== 3/20/19…a whipsaw day…Powell comes to market rescue with...
by Raynovich Rod | Mar 6, 2019 | Biopharmaceuticals
Update-3…3/11…Gene Therapy stocks go green screen! Big 5% winners: VYGR NTLA BLUE EDIT See complete list below (paste list into yahoo finance for tracking) Update-2…3/11…Market gets support from 60 Minutes-Powell comments and Gene Therapy;...
